한글목차

세포 배양 시장 - 조사 범위

TMR 조사 보고서 '세계의 세포 배양 시장'은 2025-2035년 예측 기간 동안 시장 지표에 대한 가치 있는 인사이트를 얻기 위해 과거 및 현재의 성장 동향과 기회를 연구합니다. 본 보고서는 2025년을 기준 연도, 2035년을 예측 연도로 설정하여 세계의 세포 배양 시장 수익과 예측을 제공합니다. 또한 2025-2035년 세계의 세포 배양 시장 연평균 성장률(CAGR%)도 제공합니다.

본 보고서는 광범위한 조사를 거쳐 작성되었습니다. 1차 조사에서 분석가들은 KOL(Key Opinion Leader), 업계 리더 및 의견 형성자들과의 인터뷰를 수행하는 등 연구 노력의 대부분을 차지했습니다. 2차 연구는 주요 업체들의 제품 문헌, 연차 보고서, 보도 자료 및 관련 문서를 참조하여 세포 배양 시장을 파악했습니다.

본 보고서는 세계의 세포 배양 시장 경쟁 구도를 조사했습니다. 세계의 세포 배양 시장에서 사업을 전개하는 주요 기업이 확인되고, 각 기업은 다양한 속성으로 프로파일링되고 있습니다. 기업 개요, 재무 상황, 최근 동향, SWOT 등이 본 보고서에서 소개하는 세계의 세포 배양 시장 참여 기업의 속성입니다.

세계의 세포 배양 시장 보고서에서 다루는 주요 질문

• 세계의 세포 배양 시장 비즈니스 기회는 무엇인가?
• 시장의 주요 촉진요인, 시장 성장 억제요인, 기회, 위협은 무엇인가?
• 예측 기간 동안 가장 빠른 CAGR로 성장하는 지역 시장은 어디인가?
• 2035년 세계에서 가장 높은 수익을 올릴 것으로 예상되는 부문은 무엇인가?
• 예측 기간 동안 가장 높은 CAGR로 성장할 것으로 예상되는 부문은 무엇인가?
• 세계 시장에서 사업 전개하는 각 기업 시장 포지션은 무엇인가?

세포 배양 시장 - 조사 목적 및 조사 기법

본 조사 보고서는 세계의 세포 배양 시장에 대해 연구 및 분석한 보고서입니다. 본 보고서는 연구 목적과 시장 내 주요 공급업체 및 유통업체, 제품 승인 관련 규제 환경에 대한 상세한 설명을 제공합니다.

독해 편의성을 위해 보고서는 장별 구성으로 편성되었으며, 각 부분은 소단위로 세분화되었습니다. 보고서는 적절히 배치된 방대한 양의 그래프와 표로 구성됩니다. 주요 부문의 실제 및 예상 값을 시각적으로 표현한 내용은 독자에게 시각적 매력을 제공합니다. 이는 또한 과거와 예측 기간 말 기준 주요 부문의 시장 점유율 비교를 가능하게 합니다.

본 보고서에서는 세계의 세포 배양 시장을 제품, 최종 사용자, 지역별로 분석했습니다. 각 기준의 주요 부문을 상세하게 조사하고 2035년 말 시점의 각 부문에 대한 시장 점유율을 제공합니다. 이러한 귀중한 인사이트를 통해 시장 이해관계자는 세계의 세포 배양 시장에 대한 투자에 대한 충분한 정보를 바탕으로 비즈니스 의사 결정을 내릴 수 있습니다.

목차

제1장 서문

제2장 전제조건과 조사 방법

제3장 주요 요약 : 세계 시장

제4장 시장 개요

• 소개
• 개요
• 시장 역학
• 세계의 세포 배양 시장 분석과 예측(2020-2035년)

제5장 주요 인사이트

• 주요 지역 및 국가 의료비 지출
• 세포 배양 기술의 최근 진보
• 세포 배양 기구 및 소모품의 가격 동향
• 주요 지역 및 국가 규제 시나리오
• Porter's Five Forces 분석
• PESTEL 분석
• 밸류체인 분석
• 신규 시장 참가자를 위한 시장 개척 전략
• 최종 사용자를 위한 주요 구매 지표
• 주요 업계 이벤트(파트너십, 콜라보레이션, 제품 승인, 합병 및 인수)
• 주요 경쟁이 제공하는 제품의 벤치마크

제6장 세계 시장 분석과 예측 : 제품 유형별

• 소개 및 정의
• 주요 조사 결과 및 진전
• 시장 매출 예측 : 제품 유형별(2020-2035년)
  • 기기
    • 세포 배양 용기(바이오리액터)
    • 이산화탄소 인큐베이터
    • 생물 안전 캐비닛
    • 극저온 탱크
    • 혈청 피펫
    • 세포 배양 플라스크
    • 기타
  • 배지
    • 무혈청 배지
      • 일반 무혈청 배지
      • Xeno 미포함 배지
      • 동물유 유래 성분 미포함 배지
      • 무단백질 배지
      • 화학적 정의된 배지
    • 기존 배지
    • 용원성 배양액(LB)
    • 특수 배지
    • 줄기세포 배양 배지
    • 기타 세포 배양 배지
  • 혈청
    • 태아 소 혈청
    • 신생 송아지 혈청
    • 인간 혈청
    • 기타 혈청
  • 시약
    • 알부민
      • 인간 혈청 알부민
      • 소 혈청 알부민
      • 재조합 혈청 알부민
      • 기타 알부민
    • 아미노산
    • 애착 요인
    • 성장인자와 사이토카인
    • 프로테아제 억제제
    • 트롬빈
    • 기타 시약
  • 액세서리
• 시장의 매력 : 제품 유형별

제7장 세계 시장 분석과 예측 : 용도별

• 소개 및 정의
• 주요 조사 결과 및 진전
• 시장 매출 예측 : 용도별(2020-2035년)
  • 바이오 의약품 제조
    • 단일클론항체
    • 백신
    • 세포 및 유전자 치료
    • 기타 치료법
  • 세포 및 분자 생물학
  • 연구개발, 약물시험
  • 조직 재생 및 이식
  • 유전자 공학
  • 인간의 질병의 진단
  • 기타
• 시장의 매력 : 용도별

제8장 세계 시장 분석과 예측 : 최종 사용자별

• 소개 및 정의
• 주요 조사 결과 및 진전
• 시장 매출 예측 : 최종 사용자별(2020-2035년)
  • 제약 및 생명공학 기업
  • 병원 및 진단실험실
  • 계약제조조직(CMO)
  • 학술연구기관
  • 기타
• 시장의 매력 : 최종 사용자별

제9장 세계 시장 분석과 예측 : 지역별

• 주요 조사 결과
• 시장 매출 예측 : 지역별
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카
• 시장의 매력 : 지역별

제10장 북미 시장 분석과 예측

• 미국
• 캐나다

제11장 유럽 시장 분석과 예측

• 독일
• 영국
• 프랑스
• 이탈리아
• 스페인
• 스위스
• 네덜란드
• 기타 유럽

제12장 아시아태평양 시장 분석과 예측

• 중국
• 인도
• 일본
• 한국
• 호주 및 뉴질랜드
• 기타 아시아태평양

제13장 라틴아메리카 시장 분석과 예측

• 브라질
• 멕시코
• 아르헨티나
• 기타 라틴아메리카

제14장 중동 및 아프리카 시장 분석과 예측

• GCC 국가
• 남아프리카
• 기타 중동 및 아프리카

제15장 경쟁 구도

• 시장 기업 : 경쟁 매트릭스(기업 등급별, 규모별)
• 시장 점유율 분석기업별(2024년)
• 기업 프로파일
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Lonza
  • STEMCELL Technologies
  • Miltenyi Biotec
  • HiMedia Laboratories
  • Sartorius AG
  • Becton, Dickinson and Company
  • Corning Incorporated
  • Danaher Corporation
  • FUJIFILM Irvine Scientific, Inc.
  • MP Biomedicals
  • PELOBIOTECH GmbH
  • GeminiBio LLC
  • REPROCELL Inc.
  • Sino Biological, Inc.
  • Takara Bio Inc.
  • Biowest
  • Celprogen Inc.
  • Bio-Rad Laboratories, Inc.
  • KCell Biosciences

영문목차

Cell Culture Market- Scope of Report

TMR's report on the global Cell Culture Marketstudies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the Market during the forecast period from 2025 to 2035. The report provides revenue of the global Cell Culture Marketfor the period 2025 to 2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Cell Culture Marketfrom 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Cell Culture Market .

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Cell Culture Market .

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Cell Culture Market . These serve as valuable tools for existing Market players as well as for entities interested in participating in the global Cell Culture Market .

The report delves into the competitive landscape of the global Cell Culture Market . Key players operating in the global Cell Culture Markethave been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Cell Culture Marketprofiled in this report.

Key Questions Answered in Global Cell Culture MarketReport:

• What are the opportunities in the global Cell Culture Market ?
• What are the major drivers, restraints, opportunities, and threats in the Market ?
• Which regional Market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2035?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the Market positions of different companies operating in the global Market ?

Cell Culture Market- Research Objectives and Research Approach

The comprehensive report on the global Cell Culture Marketbegins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the Market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the Market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Cell Culture Marketin terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the Market share for each of these at the end of 2035 has been provided. Such valuable insights enable Market stakeholders in making informed business decisions for investment in the global Cell Culture Market .

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Cell Culture Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Segment Definition
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Cell Culture Market Analysis and Forecasts, 2020 to 2035
  • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

• 5.1. Healthcare Expenditure across Key Regions / Countries
• 5.2. Recent Advancements in Cell Culture Technology
• 5.3. Cell Culture Instruments & Consumables Pricing Trends
• 5.4. Regulatory Scenario across Key Regions / Countries
• 5.5. PORTER's Five Forces Analysis
• 5.6. PESTEL Analysis
• 5.7. Value Chain Analysis
• 5.8. Go-to-Market Strategy for New Market Entrants
• 5.9. Key Purchase Metrics for End-users
• 5.10. Key Industry Events (Partnerships, Collaborations, Product approvals, mergers & acquisitions)
• 5.11. Benchmarking of the Products Offered by the Leading Competitors

6. Global Cell Culture Market Analysis and Forecasts, By Product Type

• 6.1. Introduction & Definition
• 6.2. Key Findings / Developments
• 6.3. Market Value Forecast By Product Type, 2020 to 2035
  • 6.3.1. Instruments
    • 6.3.1.1. Cell Culture Vessels (Bioreactors)
    • 6.3.1.2. Carbon Dioxide Incubators
    • 6.3.1.3. Biosafety Cabinets
    • 6.3.1.4. Cryogenic Tanks
    • 6.3.1.5. Serological Pipets
    • 6.3.1.6. Cell Culture Flasks
    • 6.3.1.7. Others
  • 6.3.2. Media
    • 6.3.2.1. Serum-free Media
      • 6.3.2.1.1. Common Serum-free Media
      • 6.3.2.1.2. Xeno-free Media
      • 6.3.2.1.3. Animal-free Media
      • 6.3.2.1.4. Protein-free Media
      • 6.3.2.1.5. Chemically Defined Media
    • 6.3.2.2. Classical Media
    • 6.3.2.3. Lysogeny Broth (LB)
    • 6.3.2.4. Specialty Media
    • 6.3.2.5. Stem Cell Culture Media
    • 6.3.2.6. Other Cell Culture Media
  • 6.3.3. Sera
    • 6.3.3.1. Fetal Bovine Serum
    • 6.3.3.2. Newborn Calf Serum
    • 6.3.3.3. Human Serum
    • 6.3.3.4. Other Sera
  • 6.3.4. Reagents
    • 6.3.4.1. Albumin
      • 6.3.4.1.1. Human Serum Albumin
      • 6.3.4.1.2. Bovine Serum Albumin
      • 6.3.4.1.3. Recombinant Serum Albumin
      • 6.3.4.1.4. Other Albumin
    • 6.3.4.2. Amino Acids
    • 6.3.4.3. Attachment Factors
    • 6.3.4.4. Growth Factors & Cytokines
    • 6.3.4.5. Protease Inhibitors
    • 6.3.4.6. Thrombin
    • 6.3.4.7. Other Reagents
  • 6.3.5. Accessories
• 6.4. Market Attractiveness By Product Type

7. Global Cell Culture Market Analysis and Forecasts, By Application

• 7.1. Introduction & Definition
• 7.2. Key Findings / Developments
• 7.3. Market Value Forecast By Application, 2020 to 2035
  • 7.3.1. Biopharmaceutical Production
    • 7.3.1.1. Monoclonal Antibodies
    • 7.3.1.2. Vaccines
    • 7.3.1.3. Cell and Gene Therapies
    • 7.3.1.4. Other Therapies
  • 7.3.2. Cellular and Molecular Biology
  • 7.3.3. Research and Development and Drug Testing
  • 7.3.4. Tissue Regeneration and Transplantation
  • 7.3.5. Genetic Engineering
  • 7.3.6. Diagnosis of Human Disease
  • 7.3.7. Others
• 7.4. Market Attractiveness By Application

8. Global Cell Culture Market Analysis and Forecasts, By End-user

• 8.1. Introduction & Definition
• 8.2. Key Findings / Developments
• 8.3. Market Value Forecast By End-user, 2020 to 2035
  • 8.3.1. Pharmaceutical & Biotechnology Companies
  • 8.3.2. Hospitals and Diagnostic Laboratories
  • 8.3.3. Contract Manufacturing Organizations (CMOs)
  • 8.3.4. Academic and Research Institutes
  • 8.3.5. Others
• 8.4. Market Attractiveness By End-user

9. Global Cell Culture Market Analysis and Forecasts, By Region

• 9.1. Key Findings
• 9.2. Market Value Forecast By Region
  • 9.2.1. North America
  • 9.2.2. Europe
  • 9.2.3. Asia Pacific
  • 9.2.4. Latin America
  • 9.2.5. Middle East & Africa
• 9.3. Market Attractiveness By Region

10. North America Cell Culture Market Analysis and Forecast

• 10.1. Introduction
  • 10.1.1. Key Findings
• 10.2. Market Value Forecast By Product Type, 2020 to 2035
  • 10.2.1. Instruments
    • 10.2.1.1. Cell Culture Vessels (Bioreactors)
    • 10.2.1.2. Carbon Dioxide Incubators
    • 10.2.1.3. Biosafety Cabinets
    • 10.2.1.4. Cryogenic Tanks
    • 10.2.1.5. Serological Pipets
    • 10.2.1.6. Cell Culture Flasks
    • 10.2.1.7. Others
  • 10.2.2. Media
    • 10.2.2.1. Serum-free Media
      • 10.2.2.1.1. Common Serum-free Media
      • 10.2.2.1.2. Xeno-free Media
      • 10.2.2.1.3. Animal-free Media
      • 10.2.2.1.4. Protein-free Media
      • 10.2.2.1.5. Chemically Defined Media
    • 10.2.2.2. Classical Media
    • 10.2.2.3. Lysogeny Broth (LB)
    • 10.2.2.4. Specialty Media
    • 10.2.2.5. Stem Cell Culture Media
    • 10.2.2.6. Other Cell Culture Media
  • 10.2.3. Sera
    • 10.2.3.1. Fetal Bovine Serum
    • 10.2.3.2. Newborn Calf Serum
    • 10.2.3.3. Human Serum
    • 10.2.3.4. Other Sera
  • 10.2.4. Reagents
    • 10.2.4.1. Albumin
      • 10.2.4.1.1. Human Serum Albumin
      • 10.2.4.1.2. Bovine Serum Albumin
      • 10.2.4.1.3. Recombinant Serum Albumin
      • 10.2.4.1.4. Other Albumin
    • 10.2.4.2. Amino Acids
    • 10.2.4.3. Attachment Factors
    • 10.2.4.4. Growth Factors & Cytokines
    • 10.2.4.5. Protease Inhibitors
    • 10.2.4.6. Thrombin
    • 10.2.4.7. Other Reagents
  • 10.2.5. Accessories
• 10.3. Market Value Forecast By Application, 2020 to 2035
  • 10.3.1. Biopharmaceutical Production
    • 10.3.1.1. Monoclonal Antibodies
    • 10.3.1.2. Vaccines
    • 10.3.1.3. Cell and Gene Therapies
    • 10.3.1.4. Other Therapies
  • 10.3.2. Cellular and Molecular Biology
  • 10.3.3. Research and Development and Drug Testing
  • 10.3.4. Tissue Regeneration and Transplantation
  • 10.3.5. Genetic Engineering
  • 10.3.6. Diagnosis of Human Disease
  • 10.3.7. Others
• 10.4. Market Value Forecast By End-user, 2020 to 2035
  • 10.4.1. Pharmaceutical & Biotechnology Companies
  • 10.4.2. Hospitals and Diagnostic Laboratories
  • 10.4.3. Contract Manufacturing Organizations (CMOs)
  • 10.4.4. Academic and Research Institutes
  • 10.4.5. Others
• 10.5. Market Value Forecast By Country, 2020 to 2035
  • 10.5.1. U.S.
  • 10.5.2. Canada
• 10.6. Market Attractiveness Analysis
  • 10.6.1. By Product Type
  • 10.6.2. By Application
  • 10.6.3. By End-user
  • 10.6.4. By Country

11. Europe Cell Culture Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast By Product Type, 2020 to 2035
  • 11.2.1. Instruments
    • 11.2.1.1. Cell Culture Vessels (Bioreactors)
    • 11.2.1.2. Carbon Dioxide Incubators
    • 11.2.1.3. Biosafety Cabinets
    • 11.2.1.4. Cryogenic Tanks
    • 11.2.1.5. Serological Pipets
    • 11.2.1.6. Cell Culture Flasks
    • 11.2.1.7. Others
  • 11.2.2. Media
    • 11.2.2.1. Serum-free Media
      • 11.2.2.1.1. Common Serum-free Media
      • 11.2.2.1.2. Xeno-free Media
      • 11.2.2.1.3. Animal-free Media
      • 11.2.2.1.4. Protein-free Media
      • 11.2.2.1.5. Chemically Defined Media
    • 11.2.2.2. Classical Media
    • 11.2.2.3. Lysogeny Broth (LB)
    • 11.2.2.4. Specialty Media
    • 11.2.2.5. Stem Cell Culture Media
    • 11.2.2.6. Other Cell Culture Media
  • 11.2.3. Sera
    • 11.2.3.1. Fetal Bovine Serum
    • 11.2.3.2. Newborn Calf Serum
    • 11.2.3.3. Human Serum
    • 11.2.3.4. Other Sera
  • 11.2.4. Reagents
    • 11.2.4.1. Albumin
      • 11.2.4.1.1. Human Serum Albumin
      • 11.2.4.1.2. Bovine Serum Albumin
      • 11.2.4.1.3. Recombinant Serum Albumin
      • 11.2.4.1.4. Other Albumin
    • 11.2.4.2. Amino Acids
    • 11.2.4.3. Attachment Factors
    • 11.2.4.4. Growth Factors & Cytokines
    • 11.2.4.5. Protease Inhibitors
    • 11.2.4.6. Thrombin
    • 11.2.4.7. Other Reagents
  • 11.2.5. Accessories
• 11.3. Market Value Forecast By Application, 2020 to 2035
  • 11.3.1. Biopharmaceutical Production
    • 11.3.1.1. Monoclonal Antibodies
    • 11.3.1.2. Vaccines
    • 11.3.1.3. Cell and Gene Therapies
    • 11.3.1.4. Other Therapies
  • 11.3.2. Cellular and Molecular Biology
  • 11.3.3. Research and Development and Drug Testing
  • 11.3.4. Tissue Regeneration and Transplantation
  • 11.3.5. Genetic Engineering
  • 11.3.6. Diagnosis of Human Disease
  • 11.3.7. Others
• 11.4. Market Value Forecast By End-user, 2020 to 2035
  • 11.4.1. Pharmaceutical & Biotechnology Companies
  • 11.4.2. Hospitals and Diagnostic Laboratories
  • 11.4.3. Contract Manufacturing Organizations (CMOs)
  • 11.4.4. Academic and Research Institutes
  • 11.4.5. Others
• 11.5. Market Value Forecast By Country / Sub-region, 2020 to 2035
  • 11.5.1. Germany
  • 11.5.2. UK
  • 11.5.3. France
  • 11.5.4. Italy
  • 11.5.5. Spain
  • 11.5.6. Switzerland
  • 11.5.7. The Netherlands
  • 11.5.8. Rest of Europe
• 11.6. Market Attractiveness Analysis
  • 11.6.1. By Product Type
  • 11.6.2. By Application
  • 11.6.3. By End-user
  • 11.6.4. By Country / Sub-region

12. Asia Pacific Cell Culture Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast By Product Type, 2020 to 2035
  • 12.2.1. Instruments
    • 12.2.1.1. Cell Culture Vessels (Bioreactors)
    • 12.2.1.2. Carbon Dioxide Incubators
    • 12.2.1.3. Biosafety Cabinets
    • 12.2.1.4. Cryogenic Tanks
    • 12.2.1.5. Serological Pipets
    • 12.2.1.6. Cell Culture Flasks
    • 12.2.1.7. Others
  • 12.2.2. Media
    • 12.2.2.1. Serum-free Media
      • 12.2.2.1.1. Common Serum-free Media
      • 12.2.2.1.2. Xeno-free Media
      • 12.2.2.1.3. Animal-free Media
      • 12.2.2.1.4. Protein-free Media
      • 12.2.2.1.5. Chemically Defined Media
    • 12.2.2.2. Classical Media
    • 12.2.2.3. Lysogeny Broth (LB)
    • 12.2.2.4. Specialty Media
    • 12.2.2.5. Stem Cell Culture Media
    • 12.2.2.6. Other Cell Culture Media
  • 12.2.3. Sera
    • 12.2.3.1. Fetal Bovine Serum
    • 12.2.3.2. Newborn Calf Serum
    • 12.2.3.3. Human Serum
    • 12.2.3.4. Other Sera
  • 12.2.4. Reagents
    • 12.2.4.1. Albumin
      • 12.2.4.1.1. Human Serum Albumin
      • 12.2.4.1.2. Bovine Serum Albumin
      • 12.2.4.1.3. Recombinant Serum Albumin
      • 12.2.4.1.4. Other Albumin
    • 12.2.4.2. Amino Acids
    • 12.2.4.3. Attachment Factors
    • 12.2.4.4. Growth Factors & Cytokines
    • 12.2.4.5. Protease Inhibitors
    • 12.2.4.6. Thrombin
    • 12.2.4.7. Other Reagents
  • 12.2.5. Accessories
• 12.3. Market Value Forecast By Application, 2020 to 2035
  • 12.3.1. Biopharmaceutical Production
    • 12.3.1.1. Monoclonal Antibodies
    • 12.3.1.2. Vaccines
    • 12.3.1.3. Cell and Gene Therapies
    • 12.3.1.4. Other Therapies
  • 12.3.2. Cellular and Molecular Biology
  • 12.3.3. Research and Development and Drug Testing
  • 12.3.4. Tissue Regeneration and Transplantation
  • 12.3.5. Genetic Engineering
  • 12.3.6. Diagnosis of Human Disease
  • 12.3.7. Others
• 12.4. Market Value Forecast By End-user, 2020 to 2035
  • 12.4.1. Pharmaceutical & Biotechnology Companies
  • 12.4.2. Hospitals and Diagnostic Laboratories
  • 12.4.3. Contract Manufacturing Organizations (CMOs)
  • 12.4.4. Academic and Research Institutes
  • 12.4.5. Others
• 12.5. Market Value Forecast By Country / Sub-region, 2020 to 2035
  • 12.5.1. China
  • 12.5.2. India
  • 12.5.3. Japan
  • 12.5.4. South Korea
  • 12.5.5. Australia & New Zealand
  • 12.5.6. Rest of Asia Pacific
• 12.6. Market Attractiveness Analysis
  • 12.6.1. By Product Type
  • 12.6.2. By Application
  • 12.6.3. By End-user
  • 12.6.4. By Country / Sub-region

13. Latin America Cell Culture Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast By Product Type, 2020 to 2035
  • 13.2.1. Instruments
    • 13.2.1.1. Cell Culture Vessels (Bioreactors)
    • 13.2.1.2. Carbon Dioxide Incubators
    • 13.2.1.3. Biosafety Cabinets
    • 13.2.1.4. Cryogenic Tanks
    • 13.2.1.5. Serological Pipets
    • 13.2.1.6. Cell Culture Flasks
    • 13.2.1.7. Others
  • 13.2.2. Media
    • 13.2.2.1. Serum-free Media
      • 13.2.2.1.1. Common Serum-free Media
      • 13.2.2.1.2. Xeno-free Media
      • 13.2.2.1.3. Animal-free Media
      • 13.2.2.1.4. Protein-free Media
      • 13.2.2.1.5. Chemically Defined Media
    • 13.2.2.2. Classical Media
    • 13.2.2.3. Lysogeny Broth (LB)
    • 13.2.2.4. Specialty Media
    • 13.2.2.5. Stem Cell Culture Media
    • 13.2.2.6. Other Cell Culture Media
  • 13.2.3. Sera
    • 13.2.3.1. Fetal Bovine Serum
    • 13.2.3.2. Newborn Calf Serum
    • 13.2.3.3. Human Serum
    • 13.2.3.4. Other Sera
  • 13.2.4. Reagents
    • 13.2.4.1. Albumin
      • 13.2.4.1.1. Human Serum Albumin
      • 13.2.4.1.2. Bovine Serum Albumin
      • 13.2.4.1.3. Recombinant Serum Albumin
      • 13.2.4.1.4. Other Albumin
    • 13.2.4.2. Amino Acids
    • 13.2.4.3. Attachment Factors
    • 13.2.4.4. Growth Factors & Cytokines
    • 13.2.4.5. Protease Inhibitors
    • 13.2.4.6. Thrombin
    • 13.2.4.7. Other Reagents
  • 13.2.5. Accessories
• 13.3. Market Value Forecast By Application, 2020 to 2035
  • 13.3.1. Biopharmaceutical Production
    • 13.3.1.1. Monoclonal Antibodies
    • 13.3.1.2. Vaccines
    • 13.3.1.3. Cell and Gene Therapies
    • 13.3.1.4. Other Therapies
  • 13.3.2. Cellular and Molecular Biology
  • 13.3.3. Research and Development and Drug Testing
  • 13.3.4. Tissue Regeneration and Transplantation
  • 13.3.5. Genetic Engineering
  • 13.3.6. Diagnosis of Human Disease
  • 13.3.7. Others
• 13.4. Market Value Forecast By End-user, 2020 to 2035
  • 13.4.1. Pharmaceutical & Biotechnology Companies
  • 13.4.2. Hospitals and Diagnostic Laboratories
  • 13.4.3. Contract Manufacturing Organizations (CMOs)
  • 13.4.4. Academic and Research Institutes
  • 13.4.5. Others
• 13.5. Market Value Forecast By Country / Sub-region, 2020 to 2035
  • 13.5.1. Brazil
  • 13.5.2. Mexico
  • 13.5.3. Argentina
  • 13.5.4. Rest of Latin America
• 13.6. Market Attractiveness Analysis
  • 13.6.1. By Product Type
  • 13.6.2. By Application
  • 13.6.3. By End-user
  • 13.6.4. By Country / Sub-region

14. Middle East & Africa Cell Culture Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast By Product Type, 2020 to 2035
  • 14.2.1. Instruments
    • 14.2.1.1. Cell Culture Vessels (Bioreactors)
    • 14.2.1.2. Carbon Dioxide Incubators
    • 14.2.1.3. Biosafety Cabinets
    • 14.2.1.4. Cryogenic Tanks
    • 14.2.1.5. Serological Pipets
    • 14.2.1.6. Cell Culture Flasks
    • 14.2.1.7. Others
  • 14.2.2. Media
    • 14.2.2.1. Serum-free Media
      • 14.2.2.1.1. Common Serum-free Media
      • 14.2.2.1.2. Xeno-free Media
      • 14.2.2.1.3. Animal-free Media
      • 14.2.2.1.4. Protein-free Media
      • 14.2.2.1.5. Chemically Defined Media
    • 14.2.2.2. Classical Media
    • 14.2.2.3. Lysogeny Broth (LB)
    • 14.2.2.4. Specialty Media
    • 14.2.2.5. Stem Cell Culture Media
    • 14.2.2.6. Other Cell Culture Media
  • 14.2.3. Sera
    • 14.2.3.1. Fetal Bovine Serum
    • 14.2.3.2. Newborn Calf Serum
    • 14.2.3.3. Human Serum
    • 14.2.3.4. Other Sera
  • 14.2.4. Reagents
    • 14.2.4.1. Albumin
      • 14.2.4.1.1. Human Serum Albumin
      • 14.2.4.1.2. Bovine Serum Albumin
      • 14.2.4.1.3. Recombinant Serum Albumin
      • 14.2.4.1.4. Other Albumin
    • 14.2.4.2. Amino Acids
    • 14.2.4.3. Attachment Factors
    • 14.2.4.4. Growth Factors & Cytokines
    • 14.2.4.5. Protease Inhibitors
    • 14.2.4.6. Thrombin
    • 14.2.4.7. Other Reagents
  • 14.2.5. Accessories
• 14.3. Market Value Forecast By Application, 2020 to 2035
  • 14.3.1. Biopharmaceutical Production
    • 14.3.1.1. Monoclonal Antibodies
    • 14.3.1.2. Vaccines
    • 14.3.1.3. Cell and Gene Therapies
    • 14.3.1.4. Other Therapies
  • 14.3.2. Cellular and Molecular Biology
  • 14.3.3. Research and Development and Drug Testing
  • 14.3.4. Tissue Regeneration and Transplantation
  • 14.3.5. Genetic Engineering
  • 14.3.6. Diagnosis of Human Disease
  • 14.3.7. Others
• 14.4. Market Value Forecast By End-user, 2020 to 2035
  • 14.4.1. Pharmaceutical & Biotechnology Companies
  • 14.4.2. Hospitals and Diagnostic Laboratories
  • 14.4.3. Contract Manufacturing Organizations (CMOs)
  • 14.4.4. Academic and Research Institutes
  • 14.4.5. Others
• 14.5. Market Value Forecast By Country / Sub-region, 2020 to 2035
  • 14.5.1. GCC Countries
  • 14.5.2. South Africa
  • 14.5.3. Rest of Middle East & Africa
• 14.6. Market Attractiveness Analysis
  • 14.6.1. By Product Type
  • 14.6.2. By Application
  • 14.6.3. By End-user
  • 14.6.4. By Country / Sub-region

15. Competition Landscape

• 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
• 15.2. Market Share Analysis By Company (2024)
• 15.3. Company Profiles
  • 15.3.1. Thermo Fisher Scientific Inc.
    • 15.3.1.1. Company Overview
    • 15.3.1.2. Financial Overview
    • 15.3.1.3. Product Portfolio
    • 15.3.1.4. Business Strategies
    • 15.3.1.5. Recent Developments
  • 15.3.2. Merck KGaA
    • 15.3.2.1. Company Overview
    • 15.3.2.2. Financial Overview
    • 15.3.2.3. Product Portfolio
    • 15.3.2.4. Business Strategies
    • 15.3.2.5. Recent Developments
  • 15.3.3. Lonza
    • 15.3.3.1. Company Overview
    • 15.3.3.2. Financial Overview
    • 15.3.3.3. Product Portfolio
    • 15.3.3.4. Business Strategies
    • 15.3.3.5. Recent Developments
  • 15.3.4. STEMCELL Technologies
    • 15.3.4.1. Company Overview
    • 15.3.4.2. Financial Overview
    • 15.3.4.3. Product Portfolio
    • 15.3.4.4. Business Strategies
    • 15.3.4.5. Recent Developments
  • 15.3.5. Miltenyi Biotec
    • 15.3.5.1. Company Overview
    • 15.3.5.2. Financial Overview
    • 15.3.5.3. Product Portfolio
    • 15.3.5.4. Business Strategies
    • 15.3.5.5. Recent Developments
  • 15.3.6. HiMedia Laboratories
    • 15.3.6.1. Company Overview
    • 15.3.6.2. Financial Overview
    • 15.3.6.3. Product Portfolio
    • 15.3.6.4. Business Strategies
    • 15.3.6.5. Recent Developments
  • 15.3.7. Sartorius AG
    • 15.3.7.1. Company Overview
    • 15.3.7.2. Financial Overview
    • 15.3.7.3. Product Portfolio
    • 15.3.7.4. Business Strategies
    • 15.3.7.5. Recent Developments
  • 15.3.8. Becton, Dickinson and Company
    • 15.3.8.1. Company Overview
    • 15.3.8.2. Financial Overview
    • 15.3.8.3. Product Portfolio
    • 15.3.8.4. Business Strategies
    • 15.3.8.5. Recent Developments
  • 15.3.9. Corning Incorporated
    • 15.3.9.1. Company Overview
    • 15.3.9.2. Financial Overview
    • 15.3.9.3. Product Portfolio
    • 15.3.9.4. Business Strategies
    • 15.3.9.5. Recent Developments
  • 15.3.10. Danaher Corporation
    • 15.3.10.1. Company Overview
    • 15.3.10.2. Financial Overview
    • 15.3.10.3. Product Portfolio
    • 15.3.10.4. Business Strategies
    • 15.3.10.5. Recent Developments
  • 15.3.11. FUJIFILM Irvine Scientific, Inc.
    • 15.3.11.1. Company Overview
    • 15.3.11.2. Financial Overview
    • 15.3.11.3. Product Portfolio
    • 15.3.11.4. Business Strategies
    • 15.3.11.5. Recent Developments
  • 15.3.12. MP Biomedicals
    • 15.3.12.1. Company Overview
    • 15.3.12.2. Financial Overview
    • 15.3.12.3. Product Portfolio
    • 15.3.12.4. Business Strategies
    • 15.3.12.5. Recent Developments
  • 15.3.13. PELOBIOTECH GmbH
    • 15.3.13.1. Company Overview
    • 15.3.13.2. Financial Overview
    • 15.3.13.3. Product Portfolio
    • 15.3.13.4. Business Strategies
    • 15.3.13.5. Recent Developments
  • 15.3.14. GeminiBio LLC
    • 15.3.14.1. Company Overview
    • 15.3.14.2. Financial Overview
    • 15.3.14.3. Product Portfolio
    • 15.3.14.4. Business Strategies
    • 15.3.14.5. Recent Developments
  • 15.3.15. REPROCELL Inc.
    • 15.3.15.1. Company Overview
    • 15.3.15.2. Financial Overview
    • 15.3.15.3. Product Portfolio
    • 15.3.15.4. Business Strategies
    • 15.3.15.5. Recent Developments
  • 15.3.16. Sino Biological, Inc.
    • 15.3.16.1. Company Overview
    • 15.3.16.2. Financial Overview
    • 15.3.16.3. Product Portfolio
    • 15.3.16.4. Business Strategies
    • 15.3.16.5. Recent Developments
  • 15.3.17. Takara Bio Inc.
    • 15.3.17.1. Company Overview
    • 15.3.17.2. Financial Overview
    • 15.3.17.3. Product Portfolio
    • 15.3.17.4. Business Strategies
    • 15.3.17.5. Recent Developments
  • 15.3.18. Biowest
    • 15.3.18.1. Company Overview
    • 15.3.18.2. Financial Overview
    • 15.3.18.3. Product Portfolio
    • 15.3.18.4. Business Strategies
    • 15.3.18.5. Recent Developments
  • 15.3.19. Celprogen Inc.
    • 15.3.19.1. Company Overview
    • 15.3.19.2. Financial Overview
    • 15.3.19.3. Product Portfolio
    • 15.3.19.4. Business Strategies
    • 15.3.19.5. Recent Developments
  • 15.3.20. Bio-Rad Laboratories, Inc.
    • 15.3.20.1. Company Overview
    • 15.3.20.2. Financial Overview
    • 15.3.20.3. Product Portfolio
    • 15.3.20.4. Business Strategies
    • 15.3.20.5. Recent Developments
  • 15.3.21. KCell Biosciences
    • 15.3.21.1. Company Overview
    • 15.3.21.2. Financial Overview
    • 15.3.21.3. Product Portfolio
    • 15.3.21.4. Business Strategies
    • 15.3.21.5. Recent Developments